Inventor
LEFTHERIS KATERINA
US89 patents
⚠️ This page may combine multiple inventors who share the name “LEFTHERIS KATERINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
30 patentsUS6399773B1Jun 4, 2002
Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme
BRISTOL MYERS SQUIBB CO105 citations98
US6838559B2Jan 4, 2005
Purine inhibitors of phosphodiesterase (PDE) 7
BRISTOL MYERS SQUIBB CO79 citations97
US6011029AJan 4, 2000
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO107 citations96
US6670357B2Dec 30, 2003
Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO137 citations95
US7473784B2Jan 6, 2009
Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO28 citations93
US6653304B2Nov 25, 2003
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
BRISTOL MYERS SQUIBB CO62 citations93
US7592338B2Sep 22, 2009
Pyrazole-amine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO9 citations92
US7414056B2Aug 19, 2008
Pyrazole-amide compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO12 citations92
US7396935B2Jul 8, 2008
Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO15 citations92
US7253170B2Aug 7, 2007
Pyrazole-amine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO10 citations92
US7160883B2Jan 9, 2007
Pyrrolo-triazine aniline compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO23 citations92
US7151113B2Dec 19, 2006
Pyrazole-amine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO19 citations92
US6962915B2Nov 8, 2005
Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO27 citations92
US6602883B1Aug 5, 2003
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO23 citations92
US6458783B1Oct 1, 2002
Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO29 citations92
US6387926B1May 14, 2002
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO38 citations92
US6156746ADec 5, 2000
1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents
BRISTOL MYERS SQUIBB CO36 citations92
US6455523B1Sep 24, 2002
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO17 citations91
US6867300B2Mar 15, 2005
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO45 citations90
US7605273B2Oct 20, 2009
Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO8 citations84
US7390810B2Jun 24, 2008
Pyrazole-amine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO9 citations84
US7323482B2Jan 29, 2008
Thiazolyl-based compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO12 citations84
US7169771B2Jan 30, 2007
Thiazolyl-based compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO11 citations84
US6596747B2Jul 22, 2003
Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO20 citations84
US7759343B2Jul 20, 2010
Pyrrolo-triazine aniline compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO11 citations83
US7462616B2Dec 9, 2008
Pyrrolo-triazine aniline compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO12 citations83
US7211666B2May 1, 2007
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO12 citations82
US7034151B2Apr 25, 2006
Process for preparing pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO17 citations82
US7314876B2Jan 1, 2008
Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO7 citations74
US8044040B2Oct 25, 2011
N-heterocyclic inhibitors of TNF-alpha expression
BRISTOL MYERS SQUIBB CO6 citations73
CLAREMON DAVID A
5 patentsUS8242111B2Aug 14, 2012
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A36 citations92
US8138178B2Mar 20, 2012
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A37 citations92
US8202857B2Jun 19, 2012
1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A21 citations84
US8575156B2Nov 5, 2013
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A5 citations73
US8569292B2Oct 29, 2013
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A5 citations73
VITAE PHARMACEUTICALS INC
4 patentsUS9073931B2Jul 7, 2015
Liver X receptor modulators
VITAE PHARMACEUTICALS INC5 citations84
US9006245B2Apr 14, 2015
Liver X receptor modulators
VITAE PHARMACEUTICALS INC5 citations84
US9006244B2Apr 14, 2015
Liver X receptor modulators
VITAE PHARMACEUTICALS INC5 citations84
US9416135B2Aug 16, 2016
Liver X receptor modulators
VITAE PHARMACEUTICALS INC4 citations73
PLIANT THERAPEUTICS INC
3 patentsUS10793564B2Oct 6, 2020
Amino acid compounds and methods of use
PLIANT THERAPEUTICS INC25 citations93
US11180494B2Nov 23, 2021
Substituted amino acids as integrin inhibitors
PLIANT THERAPEUTICS INC11 citations84
US11560376B2Jan 24, 2023
Amino acid compounds and methods of use
PLIANT THERAPEUTICS INC6 citations83
PHARMACOPEIA INC
2 patentsSIGNAL PHARM LLC
2 patents(unassigned)
1 patentPHARMACEOPEIA INC
1 patentLIU CHUNJIAN
1 patentCACATIAN SALVACION
1 patentShowing the top 50 of 89 patents by PatentIndex Score.